Rooseboom M - Search Results

1

Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists.

Ho KK, Auld DS, Bohnstedt AC, Conti P, Dokter W, Erickson S, Feng D, Inglese J, Kingsbury C, Kultgen SG, Liu RQ, Masterson CM, Ohlmeyer M, Rong Y, Rooseboom M, Roughton A, Samama P, Smit MJ, Son E, van der Louw J, Vogel G, Webb M, Wijkmans J, You M. Ho KK, et al. Among authors: rooseboom m. Bioorg Med Chem Lett. 2006 May 15;16(10):2724-8. doi: 10.1016/j.bmcl.2006.02.028. Epub 2006 Mar 15. Bioorg Med Chem Lett. 2006. PMID: 16540318

2

Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice.

Mihara K, Smit MJ, Krajnc-Franken M, Gossen J, Rooseboom M, Dokter W. Mihara K, et al. Among authors: rooseboom m. Eur J Immunol. 2005 Sep;35(9):2573-82. doi: 10.1002/eji.200526021. Eur J Immunol. 2005. PMID: 16094689 Free article.

3

Functional replacement of murine CXCR2 by its human homologue in the development of atherosclerosis in LDLR knockout mice.

Mihara K, Spansier M, Rooseboom M, Smit MJ, Dokter W. Mihara K, et al. Among authors: rooseboom m. Biol Pharm Bull. 2007 Jul;30(7):1231-6. doi: 10.1248/bpb.30.1231. Biol Pharm Bull. 2007. PMID: 17603159 Free article.

4

A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.

Mihara K, Almansa C, Smeets RL, Loomans EE, Dulos J, Vink PM, Rooseboom M, Kreutzer H, Cavalcanti F, Boots AM, Nelissen RL. Mihara K, et al. Among authors: rooseboom m. Br J Pharmacol. 2008 May;154(1):153-64. doi: 10.1038/bjp.2008.53. Epub 2008 Feb 25. Br J Pharmacol. 2008. PMID: 18297096 Free PMC article.

5

Induction of glutathione-S-transferase mRNA levels by chemopreventive selenocysteine Se-conjugates.

't Hoen PA, Rooseboom M, Bijsterbosch MK, van Berkel TJ, Vermeulen NP, Commandeur JN. 't Hoen PA, et al. Among authors: rooseboom m. Biochem Pharmacol. 2002 May 15;63(10):1843-9. doi: 10.1016/s0006-2952(02)00987-5. Biochem Pharmacol. 2002. PMID: 12034368

6

Bioactivation of selenocysteine Se-conjugates by a highly purified rat renal cysteine conjugate beta-lyase/glutamine transaminase K.

Commandeur JN, Andreadou I, Rooseboom M, Out M, de Leur LJ, Groot E, Vermeulen NP. Commandeur JN, et al. Among authors: rooseboom m. J Pharmacol Exp Ther. 2000 Aug;294(2):753-61. J Pharmacol Exp Ther. 2000. PMID: 10900257

7

Evaluation of the kinetics of beta-elimination reactions of selenocysteine Se-conjugates in human renal cytosol: possible implications for the use as kidney selective prodrugs.

Rooseboom M, Vermeulen NP, Andreadou I, Commandeur JN. Rooseboom M, et al. J Pharmacol Exp Ther. 2000 Aug;294(2):762-9. J Pharmacol Exp Ther. 2000. PMID: 10900258

8

Enzymatic pathways of beta elimination of chemopreventive selenocysteine Se conjugates.

Rooseboom M, Vermeulen NP, Commandeur JN. Rooseboom M, et al. Methods Enzymol. 2002;348:191-200. doi: 10.1016/s0076-6879(02)48638-7. Methods Enzymol. 2002. PMID: 11885272 No abstract available.

9

Beta-lyase-dependent attenuation of cisplatin-mediated toxicity by selenocysteine Se-conjugates in renal tubular cell lines.

Rooseboom M, Schaaf G, Commandeur JN, Vermeulen NP, Fink-Gremmels J. Rooseboom M, et al. J Pharmacol Exp Ther. 2002 Jun;301(3):884-92. doi: 10.1124/jpet.301.3.884. J Pharmacol Exp Ther. 2002. PMID: 12023515

10

Tissue distribution of cytosolic beta-elimination reactions of selenocysteine Se-conjugates in rat and human.

Rooseboom M, Vermeulen NP, Groot EJ, Commandeur JN. Rooseboom M, et al. Chem Biol Interact. 2002 Aug 15;140(3):243-64. doi: 10.1016/s0009-2797(02)00039-x. Chem Biol Interact. 2002. PMID: 12204580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page